A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

Evan M. Hersh, Steven J. O'Day, John Powderly, Khuda D. Khan, Anna C. Pavlick, Lee D. Cranmer, Wolfram E. Samlowski, Geoffrey M. Nichol, Michael J. Yellin, Jeffrey S. Weber

Research output: Contribution to journalArticlepeer-review

227 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences